HMS Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,793
Closed -$471K 218
2018
Q2
$471K Sell
4,793
-149
-3% -$16.7K 0.27% 109
2018
Q1
$551K Buy
4,942
+7
+0.1% +$785 0.37% 82
2017
Q4
$508K Sell
4,935
-256
-5% -$25.5K 0.38% 89
2017
Q3
$489K Sell
5,191
-395
-7% -$31.2K 0.42% 89
2017
Q2
$435K Hold
5,586
0.39% 93
2017
Q1
$411K Sell
5,586
-1,281
-19% -$102K 0.37% 91
2016
Q4
$541K Sell
6,867
-3,920
-36% -$305K 0.57% 65
2016
Q3
$841K Buy
+10,787
New +$783K 0.84% 50

Other funds holding CMD

HMS Capital Management's CMD Position: Q3 2018 in Review

HMS Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 4,793 shares — an estimated $471K sold.

HMS Capital Management first reported a position in CMD in Q3 2016 and held it in 8 quarters. The position peaked at $841K in Q3 2016. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • HMS Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • HMS Capital Management sold 4,793 Cantel Medical Corporation shares in Q3 2018, an estimated $471K.
  • HMS Capital Management first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 8 quarters.
  • HMS Capital Management's Cantel Medical Corporation position peaked at $841K in Q3 2016.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on HMS Capital Management's 13F filing for Q3 2018, filed 2 Nov 2018.